Your browser doesn't support javascript.
loading
Complex karyotype in patients with mantle cell lymphoma predicts inferior survival and poor response to intensive induction therapy.
Greenwell, I Brian; Staton, Ashley D; Lee, Michael J; Switchenko, Jeffrey M; Saxe, Debra F; Maly, Joseph J; Blum, Kristie A; Grover, Natalie S; Mathews, Stephanie P; Gordon, Max J; Danilov, Alexey V; Epperla, Narendranath; Fenske, Timothy S; Hamadani, Mehdi; Park, Steven I; Flowers, Christopher R; Cohen, Jonathon B.
Afiliación
  • Greenwell IB; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.
  • Staton AD; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.
  • Lee MJ; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.
  • Switchenko JM; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.
  • Saxe DF; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.
  • Maly JJ; Division of Hematology/Oncology, The Ohio State University James Cancer Hospital, Columbus, Ohio.
  • Blum KA; Division of Hematology/Oncology, The Ohio State University James Cancer Hospital, Columbus, Ohio.
  • Grover NS; Division of Hematology/Oncology, University of North Carolina at Chapel Hill Lineberger Cancer Center, Chapel Hill, North Carolina.
  • Mathews SP; Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill Lineberger Cancer Center, Chapel Hill, North Carolina.
  • Gordon MJ; Department of Medicine, OHSU Knight Cancer Institute, Portland, Oregon.
  • Danilov AV; Department of Medicine, OHSU Knight Cancer Institute, Portland, Oregon.
  • Epperla N; Department of Hematology and Oncology, Medical College of Wisconsin Cancer Center, Milwaukee, Wisconsin.
  • Fenske TS; Department of Hematology and Oncology, Medical College of Wisconsin Cancer Center, Milwaukee, Wisconsin.
  • Hamadani M; Department of Hematology and Oncology, Medical College of Wisconsin Cancer Center, Milwaukee, Wisconsin.
  • Park SI; Levine Cancer Institute, Charlotte, North Carolina.
  • Flowers CR; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.
  • Cohen JB; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.
Cancer ; 124(11): 2306-2315, 2018 06 01.
Article en En | MEDLINE | ID: mdl-29579328
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inducción de Remisión / Protocolos de Quimioterapia Combinada Antineoplásica / Aberraciones Cromosómicas / Trasplante de Células Madre Hematopoyéticas / Linfoma de Células del Manto Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Cancer Año: 2018 Tipo del documento: Article País de afiliación: Georgia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inducción de Remisión / Protocolos de Quimioterapia Combinada Antineoplásica / Aberraciones Cromosómicas / Trasplante de Células Madre Hematopoyéticas / Linfoma de Células del Manto Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Cancer Año: 2018 Tipo del documento: Article País de afiliación: Georgia